Evidence map›Paper›PMID 36353628›Full record

ReviewFrontiers in immunology2022

SARS-CoV-2 ORF8: One protein, seemingly one structure, and many functions.

Smita Vinjamuri, Lenong Li, Marlene Bouvier

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Human coronaviruses: activation and antagonism of innate immune responses.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Smita VinjamuriDepartment of Microbiology and Immunology, University of Illinois at Chicago, College of Medicine, Chicago, IL, United States.
Lenong LiDepartment of Microbiology and Immunology, University of Illinois at Chicago, College of Medicine, Chicago, IL, United States.
Marlene BouvierDepartment of Microbiology and Immunology, University of Illinois at Chicago, College of Medicine, Chicago, IL, United States.
University of Illinois Chicago · US

Funding

Understanding ERAP molecular mechanism of MHC I antigen processingR01AI114467 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BOUVIER, MARLENE · 2017 to 2021
$2.0M
Immune evasion by SARS-CoV-2: the role of HLA class IR21AI173863 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BOUVIER, MARLENE · 2023 to 2024
$440k
NIAID NIH HHS R01 AI114467NIAID NIH HHS R21 AI173863
6 · The paper itself

Abstract

SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. The genome of SARS-CoV-2 encodes nine accessory proteins that are involved in host-pathogen interaction. ORF8 is unique among these accessory proteins. SARS-CoV-2 ORF8 shares a surprisingly low amino acid sequence similarity with SARS-COV ORF8 (30%), and it is presumed to have originated from bat. Studies have shown that ORF8 exerts multiple different functions that interfere with host immune responses, including the downregulation of MHC class I molecules. These functions may represent strategies of host immune evasion. The x-ray crystal structure of ORF8 revealed an immunoglobulin-like domain with several distinguishing features. To date, there are numerous unanswered questions about SARS-CoV-2 ORF8 protein and its structure-function relationship that we discuss in this mini-review. A better understanding of how ORF8 interacts with components of the immune system is needed for elucidating COVID-19 pathogenesis and to develop new avenues for the treatment of the disease.

Indexed as

COVID-19SARS-CoV-2Amino Acid SequenceHost-Pathogen InteractionsHumansPandemicsaccessory proteinsantigen presentationCOVID-19immune evasionMHC class IORF8SARS-CoV-2

Identifiers

PMID36353628
PMCPMC9637571
OpenAlexW4307266381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.